Logo for the American Society of Clinical Oncology
Logo for the Association of Community Cancer Centers

The American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC) recently released two free online resources to help clinical research sites diversify participation in cancer clinical trials. Additionally, two manuscripts demonstrating the utility and feasibility of these resources were recently published in ASCO’s JCO Oncology Practice.

Register for the ASCO and ACCC Joint Webinar on February 17, 2023, at 11 AM (ET)

Recommendations to Diversify Clinical Trials

Research Statement on Diversifying Clinical Trial

The ASCO-ACCC research statement (see image) details specific actions to engage the entire cancer clinical trial ecosystem in expanding the participation of underrepresented individuals in research to advance progress against cancer. Review the overview of the recommendations and read the full research statement.

Additional Strategies and Resources

An annotated reference list of detailed strategies and resources is also available online. This list is intended to provide examples of strategies for research sites to increase EDI in cancer clinical trials. It may also help stimulate research to establish evidence-based strategies that demonstrate increased participation of patients historically underrepresented in clinical trials.

    Initial Work of the Collaboration

    ASCO and ACCC launched this initiative in July 2020 with a request for ideas from the research community regarding novel strategies and practical solutions to increase EDI in clinical trials. Based on the responses, the Site Self-Assessment and an Implicit Bias Training Program were developed and tested by seventy-five research sites from across the United StatesSee the full list of sites that participatedThe collaboration is led by ASCO Board Chair Lori J. Pierce, MD, FASTRO, FASCO, and ACCC Past President Randall A. Oyer, MD. EDI experts, including a Steering Group and a Patient Partners Advisory Group, have provided invaluable guidance and expertise for this initiative.

      Announcements About the Initiative

      Thank You to Our Donors:

      The ASCO-ACCC Collaboration to Increase Racial and Ethnic Diversity in Clinical Trials is funded through Conquer Cancer, the ASCO Foundation, by generous donors of the Equity, Diversity, and Inclusion Initiative.